Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

R

RAPP

Rapport Therapeutics Inc

42.26

Aug 05 • 10:23 AM ET +0.06 (0.14%)

Healthcare Biotechnology USA Mid NASD

Peers: DNLI ACAD XENE KYMR CRNX AXSM INCY KRYS BIIB NBIX

| Held by: VTI IWM VXF IWO IBB VTWO XPH SCHA DFAS IHE

Scroll to Statements

Index	RUT
Market Cap	2.02B
Enterprise Value	1.56B
Income	-107.28M
Sales	20.00M
Book/sh	9.86
Cash/sh	9.97
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	84
IPO	Jun 07, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	101.06
P/B	4.28
P/C	4.24
P/FCF	-
EV/EBITDA	-
EV/Sales	77.75
Quick Ratio	27.08
Current Ratio	27.08
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	Yes / Yes

EPS (ttm)	-2.60
EPS next Y	-4.32
EPS next Q	-0.96
EPS this Y	-20.55%
EPS next Y	-25.22%
EPS next 5Y	-17.76%
EPS past 3/5Y	-114.24% -
Sales past 3/5Y	- -
EPS Y/Y TTM	-18.14%
Sales Y/Y TTM	-
EPS Q/Q	38.38%
Sales Q/Q	-
Earnings	May 07 BMO
EPS/Sales Surpr.	30.64% 166.67%

Insider Own	40.23%
Insider Trans	-4.78%
Inst Own	76.55%
Inst Trans	3.20%
ROA	-26.83%
ROE	-28.33%
ROIC	-22.36%
Gross Margin	95.00%
Oper. Margin	-611.03%
Profit Margin	-536.38%
SMA20	1.99%
SMA50	6.79%
SMA200	30.61%
Trades

Shs Outstand	47.81M
Shs Float	28.59M
Short Float	9.41%
Short Ratio	7.32
Short Interest	2.69M
52W High	44.28 -4.56%
52W Low	13.62 210.28%
Volatility	4.89% 6.68%
ATR (14)	2.31
RSI (14)	55.09
Beta	0.95
Rel Volume	0.39
Avg Volume	367.66K
Volume	25,625

Perf Week	3.22%
Perf Month	6.39%
Perf Quarter	18.74%
Perf Half Y	54.01%
Perf YTD	39.29%
Perf Year	192.86%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	60.28
Prev Close	42.20
Price	42.26
Change	0.14%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)